Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.8K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

49
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
49
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

950
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
950
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

51
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
51

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cryptococcus detection technologies: An overview of conventional, immunological, and molecular methods, and future development directions.

Talanta·2026
Same author

The catalase gene <i>CAT2</i> and its role in the virulence of one sub-cluster of <i>Cryptococcus gattii</i> VGI clinical isolates.

Acta biochimica et biophysica Sinica·2025
Same author

Pulmonary cryptococcosis coexisting with lung cancer: a Chinese multicenter retrospective study.

Quantitative imaging in medicine and surgery·2025
Same author

Continuing immune checkpoint inhibitors after pseudoprogression improves survival in lung cancer patients: a systematic review and meta-analysis.

Journal of thoracic disease·2025
Same author

Identification of ATM1 gene involved in antifungal resistance based on CRISPR/Cas9 technology in Cryptococcus gattii.

Medical mycology·2025
Same author

A Lymphocyte Subset-Based Prediction Model for Refractory Community-Acquired Pneumonia in Immunocompetent Patients.

Diagnostics (Basel, Switzerland)·2025
Same journal

The clinical utility of bronchoalveolar lavage galactomannan result stewardship within a tertiary medical system.

Medical mycology·2026
Same journal

Cross-reactivity of Cryptococcal Antigen Lateral Flow Assay with Basidiomycetous Yeasts.

Medical mycology·2026
Same journal

Cryptococcus gattii complex infections in southern Brazil: epidemiology, clinical features, management and outcomes from a 33-year cohort.

Medical mycology·2026
Same journal

HAC1 contributes to stress adaptation and virulence in the emerging fungal pathogen Candida auris.

Medical mycology·2026
Same journal

Multicenter Study Reveals Alarming Terbinafine Resistance in Trichophyton indotineae Isolates from Iran.

Medical mycology·2026
Same journal

Human-to-animal transmission cases of the anthropophilic dermatophyte species Trichophyton tonsurans in France, 2021-2025.

Medical mycology·2026
See all related articles

Related Experiment Video

Updated: Feb 27, 2026

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks
09:18

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Published on: December 2, 2022

1.4K

Potential therapeutic targets for Cryptococcus.

Jing Liu1, Xiaozhuo Dong1, Yemei Huang2

  • 1School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong 261053, China.

Medical Mycology
|February 26, 2026
PubMed
Summary
This summary is machine-generated.

New antifungal strategies are needed to combat drug-resistant Cryptococcus infections. Targeting the fungus's metabolism offers a promising approach to reduce virulence and enhance host immunity against fungal infections.

Keywords:
Cryptococcusglucose metabolismlipid metabolismmetal metabolismprotein metabolismtherapeutic targets

More Related Videos

Biolistic Transformation of a Fluorescent Tagged Gene into the Opportunistic Fungal Pathogen Cryptococcus neoformans
07:32

Biolistic Transformation of a Fluorescent Tagged Gene into the Opportunistic Fungal Pathogen Cryptococcus neoformans

Published on: March 19, 2015

10.6K
Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

7.5K

Related Experiment Videos

Last Updated: Feb 27, 2026

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks
09:18

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Published on: December 2, 2022

1.4K
Biolistic Transformation of a Fluorescent Tagged Gene into the Opportunistic Fungal Pathogen Cryptococcus neoformans
07:32

Biolistic Transformation of a Fluorescent Tagged Gene into the Opportunistic Fungal Pathogen Cryptococcus neoformans

Published on: March 19, 2015

10.6K
Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

7.5K

Area of Science:

  • Mycology
  • Medical Mycology
  • Drug Discovery

Background:

  • Cryptococcus is an opportunistic fungal pathogen causing life-threatening infections like meningitis, particularly in immunocompromised individuals.
  • Existing antifungal drugs exhibit limitations, including drug resistance and significant side effects, necessitating novel therapeutic approaches.
  • The metabolic network of Cryptococcus is crucial for its growth and pathogenicity, presenting potential targets for intervention.

Purpose of the Study:

  • To systematically review potential therapeutic targets within the metabolic pathways of Cryptococcus.
  • To elucidate the mechanisms of action for these metabolic targets.
  • To provide a theoretical basis for developing new antifungal drugs against Cryptococcus.

Main Methods:

  • Literature review and systematic summarization of research on Cryptococcus metabolism.
  • Analysis of protein, sugar, lipid, and metal metabolism in Cryptococcus.
  • Examination of the mechanisms by which metabolic interference affects fungal virulence and host response.

Main Results:

  • Identified key metabolic pathways (protein, sugar, lipid, metal) as potential targets in Cryptococcus.
  • Detailed the mechanisms through which targeting these pathways can reduce fungal virulence.
  • Highlighted how metabolic interference can enhance the host's immune response against Cryptococcus infections.

Conclusions:

  • Interfering with Cryptococcus's metabolic network is a viable strategy for developing novel antifungal therapies.
  • Targeting metabolic pathways offers a promising avenue to overcome drug resistance and reduce side effects associated with current treatments.
  • This review provides critical insights for the development of new drugs to combat the growing threat of fungal infections.